Risk Mitigation of Drug Shortages—A New Concept for Vials Designed to Improve Fill and Finish Performance

References

1. 1.↵
   U.S. Food and Drug Association. Drug Shortages: Root Causes and Potential Solutions, 2019. FDA Web site. https://www.fda.gov/media/132058/download(accessed January 15, 2020).
2. 2.↵
   IMS Institute for Healthcare Informatics. Drug Shortages A Closer Look at Products. Suppliers, and Volume Volatility, 2011. http://www.multivu.com/assets/53215/documents/53215-IIHI-Media-Executive-Summary-Final-original.pdf (accessed January 13, 2020).
3. 3.↵
   U.S. Food and Drug Association. Frequently Asked Questions about Drug Shortages. FDA Web site. https://www.fda.gov/drugs/drug-shortages/frequently-asked-questions-about-drug-shortages#q4 (accessed May 2, 2020)
4. 4.↵
   1. Schaut R. A.,
   2. Hoff K. C.,
   3. Demartino S. E.,
   4. Denson W. K.,
   5. Verkleeren R. L.

   Enhancing Patient Safety through the Use of a Pharmaceutical Glass Designed to Prevent Cracked Containers. PDA J. Pharm. Sci. Technol. 2017, 71 (6), 511–528.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Jones L. S.,
   2. Kaufmann A.,
   3. Middaugh C. R.

   Silicone Oil Induced Aggregation of Proteins. J. Pharm. Sci. 2005, 94 (4), 918–927.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Shi G. H.,
   2. Gopalrathnam G.,
   3. Shinkle S. L.,
   4. Dong X.,
   5. Hofer J. D.,
   6. Jensen E. C.,
   7. Rajagopalan N.

   Impact of Drug Formulation Variables on Silicone Oil Structure and Functionality of Prefilled Syringe System. PDA J. Pharm. Sci. Technol. 2018, 72 (1), 50–61.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Thirumangalathu R.,
   2. Krishnan S.,
   3. Speed Ricci M.,
   4. Brems D. N.,
   5. Randolph T. W.,
   6. Carpenter J. F.

   Silicone Oil- and Agitation-Induced Aggregation of a Monoclonal Antibody in Aqueous Solution. J. Pharm. Sci. 2009, 98 (9), 3167–3181.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Waxman L.,
   2. Vilivalam V. D.

   A Comparison of Protein Stability in Prefillable Syringes Made of Glass and Plastic. PDA J. Pharm. Sci. Technol. 2017, 71 (6), 462–477.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Eberle L. G.

   Enhancing the Efficiency of Sterile Drug Product Manufacturing: Data-driven Methodologies and Industrial Applications. Dr.Sc., ETH Zürich, 2016.
10. 10.↵
    1. Boltres B.

    When Glass Meets Pharma; Editio Cantor Verlag für Medizin un Naturwissenschaften GmbH: Aulendorf, Germany, 2015; pp 46–49.
11. 11.↵
    1. Haines D.,
    2. Maurer F.,
    3. Rothhaar U.

    Why Do Pharmaceutical Glass Containers Break: The Underestimated Power of Strength Testing and Fractography. Int. Pharm. Ind. 2016, 8 (1), 88–92.

    OpenUrl
12. 12.↵
    1. Quinn G. D.

    Fractography of Ceramics and Glasses. NIST Special Publication 960-16e2; National Institute of Standards and Technology, 2016.
13. 13.↵
    Inductively Coupled Plasma Atomic Emission Spectroscopy,” in European Pharmacopoeia Convention, Bd. 10th Edition, Deutscher Apotheker Verlag, 2020, p. Chapter 2.2.57.
14. 14.↵
    U.S. Pharmacopeial Convention, General Chapter <730> Plasma Spectrochemistry. In USP 40—NF 35, USP: Rockville, MD, 2017.
15. 15.↵
    International Organization for Standardization, DIN EN ISO 7458:2004 Glass Containers—Internal Pressure Resistance—Test Methods. ISO: Geneva, 2004.
16. 16.↵
    1. Wilcoxon F.

    Individual Comparisons by Ranking Methods. Biom. Bull. 1945, 1 (6), 80–83.

    OpenUrlCrossRef
17. 17.↵
    1. Lehmann E. L.

    Nonparametrics: Statistical Methods Based on Ranks, Springer Verlag, 2006.
18. 18.↵
    1. Lehmann E. L.

    Nonparametrics: Statistical Methods Based on Ranks, McGraw-Hill: New York, 1975.
19. 19.↵
    1. Smirnoff N. V.

    Estimate of Deviation between Empirical Distribution Functions in Two Independent Samples, Bull. Moscow Univ. 1939, 2 (2), 3–16.

    OpenUrl
20. 20.↵
    1. DeGroot M. H.

    Probability and Statistics; Addison-Weasley: Reading, MA, 1991; Chapter 9.
21. 21.↵
    International Organization for Standardization, DIN EN ISO 8113:2004 Glass containers—Resistance to Vertical Load—Test method. ISO: Geneva, 2004.
22. 22.↵
    1. Hormes R.,
    2. Klause M.,
    3. Kunz A.,
    4. Roehl H.,
    5. Rothhaar U.,
    6. Thürk J.

    Process for the Treatment of a Surface, in Particular a Glass Surface. Patent DE102009042159A1, 2017.
23. 23.↵
    1. Barbe S.,
    2. Christians K.

    Gas Desorption von Gläsern (German). Vak. Techn 1962, 11 (9).
24. 24.↵
    1. Dushman S.

    Scientific Foundations of Vacuum Technique. J. Chem. Educ. 1962 39 (8), A606.
25. 25.↵
    1. Holland L.

    The Properties of Glass Surfaces; Chapman & Hall: London, 1964.
26. 26.↵
    1. Naughton J. J.

    A Solubility Determination of Some Elemental Gases in Pyrex at 1170°C. J. Appl. Phys. 1953, 24 (4), 499–500.

    OpenUrl
27. 27.↵
    1. Houwink R.

    Chemie und Technologie der Kunststoffe. 3rd ed, Akademische Verlagsgesellschaft Geest & Portig: Leipzig, 1954; Vol. I, p 423.
28. 28.↵
    1. Jackson J. D. J.,
    2. Rand B.,
    3. Rawson H.

    Glass Surface Coatings Resistant to Mechanical Damage. Thin Solid Films 1981, 77 (1–3), 5–12.

    OpenUrl
29. 29.↵
    1. Langmuir I.

    The Constitution and Fundamental Properties of Solids and Liquids. J. Am. Chem. Soc. 1916, 38 (11), 2221–2295.

    OpenUrlCrossRef
30. 30.↵
    1. Langmuir I.

    The Adsorption of Gases on Plane Surfaces of Glass, Mica and Platinum. J. Am. Chem. Soc. 1918, 40, 1361–1403.

    OpenUrlCrossRefWeb of Science
31. 31.↵
    1. Timmons C. L.,
    2. Chi Y. L.,
    3. Stefan M.

    Particulate Generation Mechanisms during Bulk Filling and Mitigation via New Glass Vial. PDA J. Pharm. Sci. Technol. 2017, 71 (5), 379–392.

    OpenUrlAbstract/FREE Full Text
32. 32.↵
    Particulate contamination: visible particles,” in European Pharmacopoeia Convention, Bd. 10th Edition, Deutscher Apotheker Verlag, 2020, p. Chapter 2.9.20.